• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经外科患者需要长期抗凝治疗的常见病症

Common Conditions Requiring Long-Term Anticoagulation in Neurosurgical Patients.

作者信息

Perez Augustus J, Grant Gerald A

机构信息

Pediatric Neurosurgery, Department of Neurosurgery, Stanford University Medical Center, 300 Pasteur Drive Room R211, MC 5325, Stanford, CA 94305, USA.

Department of Neurosurgery, Stanford University Medical Center, 300 Pasteur Drive Room R211, MC 5327, Stanford, CA 94305, USA.

出版信息

Neurosurg Clin N Am. 2018 Oct;29(4):529-535. doi: 10.1016/j.nec.2018.06.009.

DOI:10.1016/j.nec.2018.06.009
PMID:30223965
Abstract

Long-term anticoagulant therapy prevents thrombosis. Management of neurosurgical patients with conditions such as atrial fibrillation, mechanical heart valves, and other prothrombotic states necessitates application of a strategy to mitigate hemorrhagic complications of anticoagulation. Development of direct oral anticoagulants, which include the direct thrombin and factor X inhibitors, yields new considerations to be had, in particular, the introduction of reversal agents. This article reviews the more common chronic clinical entities that require the use of prolonged anticoagulant therapy with special consideration for neurosurgical patients. It also includes a discussion of established treatment strategies across available treatment options.

摘要

长期抗凝治疗可预防血栓形成。对于患有心房颤动、机械心脏瓣膜及其他血栓前状态等疾病的神经外科患者,管理时需要采用一种策略来减轻抗凝治疗的出血并发症。直接口服抗凝剂的发展,包括直接凝血酶抑制剂和X因子抑制剂,带来了新的考虑因素,尤其是逆转剂的引入。本文回顾了更常见的需要长期抗凝治疗的慢性临床病症,并特别考虑了神经外科患者。还讨论了现有治疗选择中的既定治疗策略。

相似文献

1
Common Conditions Requiring Long-Term Anticoagulation in Neurosurgical Patients.神经外科患者需要长期抗凝治疗的常见病症
Neurosurg Clin N Am. 2018 Oct;29(4):529-535. doi: 10.1016/j.nec.2018.06.009.
2
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).静脉血栓栓塞症、易栓症、抗栓治疗与妊娠:美国胸科医师学会循证临床实践指南(第8版)
Chest. 2008 Jun;133(6 Suppl):844S-886S. doi: 10.1378/chest.08-0761.
3
Postoperative Anticoagulation After Neurologic Surgery.神经外科手术后的抗凝治疗
Neurosurg Clin N Am. 2018 Oct;29(4):575-583. doi: 10.1016/j.nec.2018.06.008. Epub 2018 Aug 16.
4
[New agents and challenges in the antithrombotic management of arterial diseases].[动脉疾病抗栓治疗的新药物与挑战]
Orv Hetil. 1997 Jan 12;138(2):59-65.
5
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).心房颤动合并心脏瓣膜病的抗栓治疗:欧洲心律协会(EHRA)和欧洲心脏病学会血栓工作组的联合共识文件,得到 ESC 心脏瓣膜病工作组、南非心脏协会(SA Heart)、心律学会(HRS)、亚太心律学会(APHRS)、南非心脏协会(SA Heart)和拉丁美洲心脏刺激和电生理学会(SOLEACE)的认可。
Europace. 2017 Nov 1;19(11):1757-1758. doi: 10.1093/europace/eux240.
6
Anticoagulation after artificial valve replacement with or without atrial fibrillation: how much is really needed?人工瓣膜置换术后无论有无心房颤动的抗凝治疗:究竟需要多少抗凝药物?
Thromb Haemost. 1999 Sep;82 Suppl 1:130-5.
7
Reversal of Systemic Anticoagulants and Antiplatelet Therapeutics.全身抗凝剂和抗血小板治疗的逆转
Neurosurg Clin N Am. 2018 Oct;29(4):537-545. doi: 10.1016/j.nec.2018.06.005.
8
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.“真实世界”的心房颤动抗栓治疗:EORP-AF 初步调查。
Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.
9
Use of oral anticoagulants in older patients.
Drugs Aging. 2000 Jun;16(6):409-35. doi: 10.2165/00002512-200016060-00003.
10
Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.非维生素K拮抗剂口服抗凝药在心血管疾病管理中的应用:证据与未解决的问题
J Clin Pharm Ther. 2014 Apr;39(2):118-35. doi: 10.1111/jcpt.12122. Epub 2014 Jan 3.